Aurélie Swalduz

High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR

Souad Assaad, Virginie Avrillon, Marie-Line Fournier et al. · European Journal of Cancer · 2020 · 124 citations · Full text

Viral Diagnostics, Medicine, Covid-19 Pandemic +8

Brief Report: Severe Sotorasib-Related Hepatotoxicity and Non-Liver Adverse Events Associated With Sequential Anti–Programmed Cell Death (Ligand)1 and Sotorasib Therapy in KRASG12C-Mutant Lung Cancer

Ali Chour, Julie Denis, Céline Mascaux et al. · Journal of Thoracic Oncology · 2023 · 69 citations · Full text

Medicine, Liver Physiology, Apoptosis +11

Clinical Relevance of an Amplicon-Based Liquid Biopsy for Detecting<i>ALK</i>and<i>ROS1</i>Fusion and Resistance Mutations in Patients With Non–Small-Cell Lung Cancer

Laura Mezquita, Aurélie Swalduz, Cécile Jovelet et al. · JCO Precision Oncology · 2020 · 48 citations · Full text

Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with <i>BRAF</i> -Mutant Metastatic Non–Small Cell Lung Cancer

Sandra Ortiz‐Cuaran, Laura Mezquita, Aurélie Swalduz et al. · Clinical Cancer Research · 2020 · 44 citations · Full text

Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program

Oliver Illini, Maximilian J. Hochmair, Hannah Fabikan et al. · Therapeutic Advances in Medical Oncology · 2021 · 44 citations · Full text